Overview of Dr. Izar
Dr. Benjamin Izar is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Giessen Faculty of Medicine and has been in practice 7 years. He is one of 121 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 370 doctors at New York-Presbyterian Hospital who specialize in Oncology. He also speaks multiple languages, including German. He has more than 80 publications and over 500 citings.
Office
161 Fort Washington Ave
Fl 9
New York, NY 10032
Education & Training
Massachusetts General HospitalInternship, Internal Medicine, 2011 - 2012
University of Giessen Faculty of MedicineClass of 2010
Certifications & Licensure
NY State Medical License 2019 - 2027
MA State Medical License 2014 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 6 citationsA single-nucleus and spatial transcriptomic atlas of the COVID-19 liver reveals topological, functional, and regenerative organ disruption in patients.Yered Pita-Juarez, Dimitra Karagkouni, Nikolaos Kalavros, Johannes C Melms, Sebastian Niezen
Genome Biology. 2025-03-14 - Hepatic stellate cells control liver zonation, size and functions via R-spondin 3.Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang, Qiuyan Sun, Chuan Yin
Nature. 2025-03-12 - micronuclAI enables automated quantification of micronuclei for assessment of chromosomal instability.Miguel A Ibarra-Arellano, Lindsay A Caprio, Aroj Hada, Niklas Stotzem, Luke L Cai
Communications Biology. 2025-03-04
Press Mentions
New Insights into Melanoma Brain MetastasesJuly 15th, 2022- New Insights into Melanoma Brain MetastasesJuly 15th, 2022
- CUIMC Update - May 3, 2021May 3rd, 2021
- Join now to see all
Grant Support
- Multi-cellular interactions defining the human brain metastatic nicheCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2028
- The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
- The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
- The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
- Mechanisms of liver metastasis and associated resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2021–2026
- Mechanisms of liver metastasis and associated resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2021–2026
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
